期刊文献+

C肽与颈动脉内膜中层厚度的相关性研究 被引量:2

The correlation between serum C-peptide and intima-media thickness of carotid artery
原文传递
导出
摘要 目的通过测定不同C肽(C-P)水平患者的颈动脉内膜中层厚度(IMT),研究C-P与动脉粥样硬化的关系。方法以正常糖代谢、糖耐量减低及2型糖尿病病程小于5年的112例患者为研究对象,根据C-P三分位间距分为A、B、C组,应用彩色多普勒超声仪测定颈动脉IMT,并测量腰围、体质指数、血糖、血脂、尿酸等,各组间进行单因素方差分析,差异有统计学意义的指标与C-P水平进行Pearson相关分析,同时记录用药情况进行行×列x^2检验。结果各组间IMT的差异有统计学意义(P〈0.05),B组和C组高于A组(P〈0.05);同时腰围、体质指数、尿酸、甘油三酯存在差异且与C-P呈正相关;三组间高密度脂蛋白胆固醇差异有统计学意义(P〈0.05),C组明显低于A组(P〈0.05),B组与A组无明显统计学差异(P〉0.05),且HDL-C与C-P呈负相关。结论随着C-P水平的升高IMT增加,在胰岛素抵抗及病程小于5年的2型糖尿病中升高的C-P可能反映动脉粥样硬化的发生。 Objective To study the correlation between serum C-peptide and the intima-media thickness(IMT) of carotid artery. Methods A total of 112 patients with normal glucose metabolism, impaired glucose tolerance and type 2 diabetes(〈5 years in duration)were divided into group A, B, C according to 33 and 66 percentile values of C- peptide. The IMT were measured by color Doppler ultrasound instrument. The basal values of waist circumferences (WC), body mass index(BMI), lipid, glucose, and uric acid (UA) were recorded. The comparison of differences between the three groups was assessed by ANOVA and Chi-square test. Pearson correlation was employed to assess the relationship between C-peptide and biomedical parameters. Results There were differences in the IMT among 3 groups (P〈0.05). The IMT in group B and C was higher than in group A(P〈0.05). Meanwhile, there were differences in WC, BMI, UA, triglycerides (TG), high density lipoprotein-cholesterol(HDL-C) among 3 groups. C-peptide level was positively associated with WC, BMI, UA, TG, but negatively with HDL-C. Conclusions IMT of carotid artery increases along with the increasing of C-peptide level. The C-peptide may be associated with atherosclerosis in type 2 diabetic patients with insulin resistance and duration less than 5 years.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2011年第9期688-690,共3页 Chinese Journal of Diabetes
关键词 C肽 动脉粥样硬化 胰岛素抵抗 糖尿病 2型 内膜中层厚度 C-peptide Atherosclerosis Insulin resistance Diabetes, type 2 Intima-media thickness
  • 相关文献

参考文献8

  • 1Walcher D, Marx N. Advanced glycation end products and Cpeptide- modulators in diabetic vasculopathy and atherosclerosis. Semin Immunopathol, 2009,31 : 103-111. 被引量:1
  • 2Johansson BL, Borg K, Femqvist-Forbes E, et al. Benefifial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med, 2000, 17: 181-189. 被引量:1
  • 3Ekberg K, Brismar T, Johansson BL, et al. Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes, 2003, 52..536-541. 被引量:1
  • 4Aronow WS, Schoenfeid MR, Paul P. Risk factors for extracranial internal or common carotid arterial disease in persons aged 60 years and older. Am J Cardiol, 1989, 63:881. 被引量:1
  • 5Marx N, Waleher D, Raichle C, et al. C-peptide eolocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterio scler Thromb Vase Biol, 2004, 24: 540-545. 被引量:1
  • 6Walcher D, Aleksic M, Jerg V, et al. C-peptide induces chemotaxis of human CD4-positive cells; involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase. Diabetes, 2004, 53 : 1664-1670. 被引量:1
  • 7AI-Rasheed NM, Chana RS, Baines RJ, et al. Ligand-independent activation of peroxisome proliferator-activated receptor-gamma by insulin and C-peptide in kidney proximal tubular cells : dependent on phosphatidylinositol 3-kinase activity. J Biol Chem, 2004, 279:747-754. 被引量:1
  • 8Walcher D, Babiak C, Poletek P, et al. C-peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signalregulated kinasel/2. Circ Res, 2006, 99..pp1181-1187. 被引量:1

同被引文献37

  • 1Yang W, Lu J, Weng J,et al. Prevalence of diabetes among menand women in China [ J ]. N Engl J Med, 2010, 362( 12): 1090-101. 被引量:1
  • 2Wahren J, Ekberg K, Johansson J, et al. Role of C-peptide in hu-man physiology [ J] . Am J Physiol Endocrinol Metab,2000,278(5): E759-768. 被引量:1
  • 3Lebherz C,Marx N. C-peptide and its career from innocent bystanderto active player in diabetic atherogenesis [ J ]. Curr Atheroslcer Rep,2013,15(7): 339. 被引量:1
  • 4Buse JB, Polonsky KS, BurantCF. Type 2 diabetes mellitus[ M]//Kronenberg HM,Melmed S,Polonsky KS,et al. Williams Textbookof Endocrinology(11th ed) . Philadelphia: PA,Saunders Elsevier,2008; 363-390. 被引量:1
  • 5Besser RE, Jones AG, McDonald TJ, et al. The impact of insulinadministration during the mixed meal tolerance test [ J ]. DiabetMed, 2012,29(10) : 1 279-284. 被引量:1
  • 6Jones AG, Hattersley AT. The clinical utility of C-peptide measure-ment in the care of patients with diabetes [ J]. Diabet Med, 2013,30(7) : 803-817. 被引量:1
  • 7Thanabalasingham G, Pal A, Selwood MP, et al. Systematic assess-ment of etiology in adults with a clinical diagnosis of young-onsettype 2 diabetes is a successful strategy for identifying maturity-onsetdiabetes of the young [ J ]. Diabetes Care, 2012, 35 ( 6 ) : 1206-212. 被引量:1
  • 8Johansson BL, Borg K, Femqvist-Forbes E, et al. Benefifial effectsof C-peptide on incipient nephropathy and neuropathy in patientswith type 1 diabetes mellitus [ J]. Diabet Med, 2000, 17(3):181-189. 被引量:1
  • 9Ekberg K, Brismar T, Johansson BL, et al. Amelioration of sensorynerve dysfunction by C-peptide in patients with type 1 diabetes [ J].Diabetes, 2003,52(2) : 536-541. 被引量:1
  • 10Ross R. Atherosclerosis-an inflammatory disease [J]. N Engl JMed, 1999, 340(2): 115-126. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部